Terns Pharmaceuticals, Inc. (TERN) EPS (Basic) (2020 - 2023)
Terns Pharmaceuticals (TERN) has disclosed EPS (Basic) for 4 consecutive years, with -$0.29 as the latest value for Q4 2023.
- For the quarter ending Q4 2023, EPS (Basic) rose 33.73% year-over-year to -$0.29, compared with a TTM value of -$1.27 through Dec 2023, down 190.22%, and an annual FY2023 reading of -$1.27, up 23.95% over the prior year.
- EPS (Basic) was -$0.29 for Q4 2023 at Terns Pharmaceuticals, up from -$0.42 in the prior quarter.
- Across five years, EPS (Basic) topped out at $8.45 in Q4 2020 and bottomed at -$45.2 in Q3 2020.
- Average EPS (Basic) over 4 years is -$6.78, with a median of -$0.51 recorded in 2021.
- Peak annual rise in EPS (Basic) hit 99.06% in 2021, while the deepest fall reached 106.51% in 2021.
- Year by year, EPS (Basic) stood at $8.45 in 2020, then crashed by 106.51% to -$0.55 in 2021, then grew by 20.44% to -$0.44 in 2022, then surged by 33.73% to -$0.29 in 2023.
- Business Quant data shows EPS (Basic) for TERN at -$0.29 in Q4 2023, -$0.42 in Q3 2023, and -$0.25 in Q2 2023.